tirzepatide osa fda Lilly Rises on Approval of Weight-Loss Drug Zepbound for Sleep Apnea FDA's First GLP-1 Approval for
Description
Stop using the medication at least 2 months before a planned pregnancy to allow the peptide to clear from your body

Mounjaro (tirzepatide) is not FDA-approved for weight loss, but its active ingredient can help with weight management.
GLP1 therapy is now approved for adolescents with type 2 diabetes and obesity
:max_bytes(150000):strip_icc()/GettyImages-2126120280-94c8334d07474c6883f6bb568b95693f.jpg)
DEXA-tracked results and ongoing medical support

Compare top GLP-1 agonists for weight lossSemaglutide vs
